All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
MRNA total return snapshot: MRNA returned +613.27% over the past year and +589.08% YTD, with dividends reinvested. Since Dec. 7, 2018, MRNA is up +992.53% in nominal total return, or +35.73%/yr, and is currently −58.06% below its total-return high on Aug. 9, 2021.
Data ending Mon Oct. 5, 2026
| Fri 2018-12-07💬 to Mon 2026-10-05 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| MRNA × |
+992.53%
+35.73%/yr |
+4.76%/yr
R2=0.014 |
||||
| Moderna Inc NASDAQ Common Stock | ||||||
| Fri 2018-12-07💬 to Mon 2026-10-05 |
Start
Value |
End
Value |
|---|---|---|
| MRNA × |
$10,000.00
2018-12-07 |
$109,252.69
2026-10-05 |
| YTD | YoY | |
|---|---|---|
| MRNA × | +589.08% | +613.27% |
|
Current
Drawdown |
Worst
Drawdown |
|
|---|---|---|
| MRNA × |
−58.06%
on 2026-10-05 from 2021-08-09 peak |
−95.38%
on 2025-11-20 from 2021-08-09 peak |
| Period ending Mon 2026-10-05 | 1 yr | 2 yr | 3 yr | 5 yr | 10 yr |
|---|---|---|---|---|---|
| MRNA × | +613.27% |
+237.56% +83.73%/yr |
+97.35% +25.43%/yr |
−38.81% −9.36%/yr |
— |
| Year | MRNA |
|---|---|
| 2026 (YTD) | +589.08% |
| 2025 | −29.08% |
| 2024 | −58.19% |
| 2023 | −44.63% |
| 2022 | −29.28% |
| 2021 | +143.11% |
| 2020 | +434.10% |
| 2019 | +28.09% |
| 2018 | −17.90% |
